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Abstract
Purpose This study aims to report a novel finding of
posterior subhyaloid precipitates (PSPs) in two patients
with cytomegalovirus (CMV) retinitis.
Methods A small case series was conducted.
Results Clinical findings, treatment, and follow-up of two
patients with CMV and PSPs are presented.
Conclusions Inflammatory precipitates may collect in the





The AIDS epidemic has provided an opportunity to study
the course and clinical features of cytomegalovirus (CMV)
retinitis, which is a leading cause of blindness in these
immunocompromised patients. The CMV retinitis lesions
may develop in all areas of the retina, although the majority
of early lesions are adjacent to blood vessels [1]. Secondary
rhegmatogenous retinal detachment (RD) often leads to
severe vision loss and occurs in 15–40% of eyes at some
point during the course of the disease [2, 3]. Mild vitreous
and anterior chamber inflammatory reactions are almost
invariably present in a patient with active CMVretinitis, but
moderate to severe intraocular inflammation is uncommon
[4]. We describe two patients in whom a novel finding of
posterior subhyaloid precipitates (PSPs) was documented
with fundus photography and spectral-domain optical
coherence tomography (OCT).
Case presentation 1
A 50-year-old HIV-positive African-American male, with CD4
count of 46 cells/ml, presented with sudden floaters in the left
eye. Visual acuity was 20/20 in the right eye and 20/25 in the
left eye. Slit lamp examination demonstrated clear cornea in
both eyes, no anterior chamber cells in the right eye, and rare
cells in the left eye. The lens was clear in both eyes. Fundus
examination of the left eye revealed a large 7×4 disk diameter
(DD) irregular lesion superonasal to the optic nerve consisting
ofretinalwhiteningwithgranularappearanceandcharacteristic
isolated “satellite” lesions along its edge. Few hemorrhages
were present within the lesion. Minimal vitreous inflam-
mation was present over the involved retina (Fig. 1a).
The diagnosis of cytomegalovirus retinitis was made
based on the fundus examination and clinical history.
The patient was admitted for induction therapy with
intravenous ganciclovir, 5 mg/kg, and was re-started on
highly active antiretroviral therapy (HAART) therapy.
Oneweeklater, white granular subhyaloid opacities located
2DDbelowtheinferotemporalarcadeandawayfromthemain
CMV lesion were observed on fundus examination (Fig. 1b,
c). A spectral-domain optical coherence tomography (SD-
OCT) demonstrated hyperreflective round opacities clearly
located in the space between the posterior hyaloid and the
retina. (Fig. 1d). After 10 days of induction with intravenous
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DOI 10.1007/s12348-011-0032-zganciclovir, the patient was switched to oral valganciclovir
900 mg twice per day. Twelve days after presentation, the
superonasal CMV lesion matured into a grayish gliotic scar
with several atrophic retinal holes and a localized RD. One
month after the diagnosis of CMV and 2 weeks after the
appearance of the RD, the SD-OCT showed that the posterior
hyaloid was still attached to the retina over the area of CMV
lesion, bridging the retinal holes and keeping a localized
rhegmatogenous RD stable (Fig. 2a, b).
Four months after the diagnosis, while still on oral
valganciclovir maintenance dose, the localized RD
remained stable with attached posterior hyaloid (Fig. 3a,
b). The PSPs resolved, but a new small necrotic lesion
appeared superior to the optic nerve. A week later,
another satellite lesion developed, and the patient’so r a l
valganciclovir dose was increased from 900 mg daily to
900 mg twice daily. In addition, an intravitreal ganci-
clovir injection (2 mg/0.05 ml) was administered
(Fig. 3c). CD4 was 57/mm
3. The vision in the left eye
was stable at 20/25. One week after intravitreal injection
of ganciclovir, the RD progressed threatening the macula
and lens-sparing pars plana vitrectomy (PPV) with
silicone oil and ganciclovir implant (Vitrasert) was
performed. Four months after the surgery, vision was 20/
25 and retina was attached under silicone oil (Fig. 4a, b).
CD4 increased to 125/mm
3.
Case presentation 2
A 41-year-old healthy white female presented with
blurry vision and floaters in the right eye for 4 weeks.
She was referred by an outside ophthalmologist for
possible acute retinal necrosis and was initiated on
valacyclovir hydrochloride (Valtrex) 1 g three times
daily. The patient had a history of three episodes of
shingles involving her scalp, right torso, and leg. The
most recent episode occurred 2 months prior. She also
Fig. 1 a Superonasal CMV retinitis lesion with retinal granular
necrotic appearance and few hemorrhages at the time of diagnosis. b
Two weeks after diagnosis, inferior posterior subhyaloid precipitates
(PSPs) were observed. c Fundus photo showing the PSPs below
inferotemporal arcade. d Spectral-domain optical coherence tomogra-
phy showing multiple PSPs
Fig. 2 a Fundus photo showing thinned retina and RD. b Showing the posterior hyaloid attached to the retina with overlying inflammation
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denied any prior ocular history.
Best corrected visual acuity was 20/25 OD and 20/20
OS. Slit lamp examination demonstrated diffuse white
keratic precipitates in the right eye with 2+ anterior
chamber cell and no cell in the left eye. The lens was clear
in both eyes. Dilated fundus examination showed 3+
vitreous cell in the right eye and extensive retinal necrosis
with whitening and hemorrhage superiorly (Fig. 5a).
Fundus evaluation of the left eye was unremarkable.
OCT evaluation of the right eye demonstrated no
evidence of fluid in the macula, but demonstrated the
presence of PSPs overlying the retina away from the
retinitis lesion, along the inferotemporal arcade (Fig. 5b–d).
The patient underwent an anterior chamber tap for
viral PCR studies and was treated with intravitreal
ganciclovir 2 mg/0.05 ml. PCR revealed CMV. HIV
test was negative. Three weeks after presentation, she
had received a total of four intravitreal ganciclovir
injections and barricade laser superiorly by her local
ophthalmologist. Best corrected visual acuity was 20/25
OD and 20/20 OS. The keratic precipitates decreased
and trace anterior chamber cell was present in the right
eye. Fundus examination showed laser demarcating and
improved retinal necrosis with pigmentary changes and
mild residual whitening and hemorrhages (Fig. 6). The
patient was continued on oral valganciclovir 900 mg twice
daily and was scheduled for an immunology evaluation.
Fig. 3 a, b Four months after the diagnosis, spectral-domain OCT
cuts through the superonasal CMV lesion demonstrate detached thin
necrotic retina with multiple discontinuities and persistent hyaloidal
attachment bridging the retinal holes. c Fundus photography demon-
strates two small new necrotic retinal lesions above the optic nerve
and resolution of the inferior PSPs
Fig. 4 a Fundus photos 2 months after PPV with silicone oil and
ganciclovir implant. b OCT showing attached macula
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We present two cases showing a peculiar finding of PSPs
occurring in CMV retinitis. Such precipitates have not been
previously well documented and reported; therefore, the
fundus photos and spectral-domain OCTs presented here are
unique in the literature. The OCTs clearly show that these
precipitates are located between the posterior hyaloid and
the retina and therefore appear to be distinct from vitreous
precipitates, which have been previously reported. The
curvilinear organization of PSPs in the posterior segment
suggest that they descent with gravity and collect along the
attachment of the posterior hyaloid to underlying retina.
These PSPs cleared during the course of treatment and
therefore may potentially be followed as another clinical
sign of response to therapy. We can speculate that because
the PSPs clear with treatment, they are most likely made up
of inflammatory cells. In conclusion, we present a novel
finding of posterior subhyaloid precipitates, which were
clearly documented by the spectral-domain OCT. We expect
that these cases will contribute to the further characteriza-
Fig. 6 Laser demarcation is observed with residual whitening and
retinal hemorrhages
Fig. 5 a Right eye with extensive retinal necrotic lesion with overlying hemorrhages. b SD-OCT image showing a normal macula. c, d SD-OCT
demonstrating the posterior subhyaloid precipitates
44 J Ophthal Inflamm Infect (2012) 2:41–45tion of the CMV retinitis manifestation in the era of
HAART and OCT imaging.
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